|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61P 19/02 |
| (11) | Number of the document | 3260128 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17183045.8 |
| Date of filing the European patent application | 2011-04-28 | |
| (97) | Date of publication of the European application | 2017-12-27 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-29 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 329078 P | 2010-04-28 | US |
| (72) |
ZHENG, Xincheng, US
LIU, Yang, US
WU, Wei, US
ZHENG, Pan, US
|
| (73) |
Oncolmmune, Inc.,
9430 Key West Avenue, Suite 113, Rockville, MD 20850,
US
|
| (54) | MEDICAL USE OF SOLUBLE CD24 |
| MEDICAL USE OF SOLUBLE CD24 |